Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT06183918
Eligibility Criteria:
Inclusion Criteria:
* 18 years and older
* Those who applied to the emergency department with the complaint of nosebleeds
* Those who agreed to participate in the study by giving written consent
Exclusion Criteria:
* posterior epistaxis
* history of nose or pharynx surgery in the last 3 months,
* facial and head trauma,
* unstable vital signs,
* who applied for the second time with a recurrent bleeding
* history of allergy to TXA,
* subarachnoid hemorrhage,
* coagulation disorders such as hemophilia, hereditary telangiectasia, von Willebrand disease, etc.
* thromboembolic disease
* history of convulsions
* intracerebral processes
* pregnant or lactating
* who wished to withdraw from the study at any stage of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
92 Years
Study:
NCT06183918
Study Brief:
Protocol Section:
NCT06183918